High-rate hepatitis and low-rate rejection induced late morbidity and mortality in long-term follow-up after liver transplantation.
Caccamo
L
L
Centro Trapianto Fegato, Ospedale Maggiore IRCCS, Università degli Studi, Milan, Italy. chirtrap@imiucca.csi.unimi.it
Rossi
G
G
Gridelli
B
B
Maggi
U
U
Reggiani
P
P
Colledan
M
M
Fassati
L R
LR
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology*; D006509:Hepatitis B / Q000453:epidemiology / Q000601:surgery*; D006526:Hepatitis C / Q000453:epidemiology / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D012008:Recurrence; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine